Andrographolide inhibits prostate cancer by targeting cell cycle regulators, CXCR3 and CXCR7 chemokine receptors

Cell Cycle

Volumn 15, Issue 6, 2016, Pages 819-826

  Mir, Hina ^a   Kapur, Neeraj ^a   Singh, Rajesh ^a   Sonpavde, Guru ^b   Lillard, James W ^a   Singh, Shailesh ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

Author keywords

Andrographolide; Cell cycle; chemokine; chemokine receptor and prostate cancer; CXCL11; CXCR3; CXCR7; Cyclins

Indexed keywords

ANDROGRAPHOLIDE; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR7; CXCL11 CHEMOKINE; CYCLIN A2; CYCLIN B1; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN E2; CYCLINE; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; CCNB1 PROTEIN, HUMAN; CCNE2 PROTEIN, HUMAN; CDK1 PROTEIN, HUMAN; CELL CYCLE PROTEIN; CHEMOKINE RECEPTOR CXCR; CXCL11 PROTEIN, HUMAN; CXCR3 PROTEIN, HUMAN; CXCR7 PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE; DITERPENE; HISTONE; NUCLEAR PROTEIN; PLANT EXTRACT; PROTEIN TYROSINE KINASE; WEE1 PROTEIN, HUMAN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL MIGRATION; CELL VIABILITY; HUMAN; IN VITRO STUDY; MALE; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; ANDROGRAPHIS; ANTAGONISTS AND INHIBITORS; CELL MOTION; CELL SURVIVAL; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; EPITHELIUM CELL; G1 PHASE CELL CYCLE CHECKPOINT; G2 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION REGULATION; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PROSTATE; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANDROGRAPHIS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; CHEMOKINE CXCL11; CYCLIN B1; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASES; CYCLINS; DITERPENES; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; G1 PHASE CELL CYCLE CHECKPOINTS; G2 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONES; HUMANS; MALE; NUCLEAR PROTEINS; PHOSPHORYLATION; PLANT EXTRACTS; PROSTATE; PROTEIN-TYROSINE KINASES; RECEPTORS, CXCR; RECEPTORS, CXCR3; RETINOBLASTOMA PROTEIN; SIGNAL TRANSDUCTION;

EID: 84962033896     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.1080/15384101.2016.1148836     Document Type: Article

References (46)

1. A.Saklani, S.K.Kutty. Plant-derived compounds in clinical trials. Drug Discov Today 2008; 13:161-71; PMID:18275914; http://dx.doi.org/10.1016/j.drudis.2007.10.010
2. S.Gao, M.Hu. Bioavailability challenges associated with development of anti-cancer phenolics. Mini Rev Med Chem 2010; 10:550-67; PMID:20370701; http://dx.doi.org/10.2174/138955710791384081
3. A.Panossian, A.Hovhannisyan, G.Mamikonyan, H.Abrahamian, E.Hambardzumyan, E.Gabrielian, G.Goukasova, G.Wikman, H.Wagner. Pharmacokinetic and oral bioavailability of andrographolide from andrographis paniculata fixed combination Kan Jang in rats and human. Phytomedicine: International Journal of phytotherapy and phytopharmacology 2000; 7:351-64; PMID:11081986; http://dx.doi.org/10.1016/S0944-7113(00)80054-9
4. H.W.Chen, C.S.Huang, C.C.Li, A.H.Lin, Y.J.Huang, T.S.Wang, H.T.Yao, C.K.Lii. Bioavailability of andrographolide and protection against carbon tetrachloride-induced oxidative damage in rats. Toxicol Appl Pharm 2014; 280:1-9; PMID:NOT_FOUND; http://dx.doi.org/10.1016/j.taap.2014.07.024
5. S.Rajagopal, R.A.Kumar, D.S.Deevi, C.Satyanarayana, R.Rajagopalan. Andrographolide, a potential cancer therapeutic agent isolated from Andrographis paniculata. J Exp Ther Oncol 2003; 3:147-58; PMID:14641821; http://dx.doi.org/10.1046/j.1359-4117.2003.01090.x
6. S.K.Hung, L.C.Hung, C.D.Kuo, K.Y.Lee, M.S.Lee, H.Y.Lin, Y.J.Chen, S.L.Fu. Andrographolide sensitizes ras-transformed cells to radiation in vitro and in vivo. Int J Radiat Oncol Biol Phys 2010; 77:1232-9; PMID:20610044; http://dx.doi.org/10.1016/j.ijrobp.2010.01.007
7. M.Darash-Yahana, E.Pikarsky, R.Abramovitch, E.Zeira, B.Pal, R.Karplus, K.Beider, S.Avniel, S.Kasem, E.Galun, et al. Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis. FASEB J: Off Pub FedAm Soc Exp Biol 2004; 18:1240-2; PMID:15180966
8. J.P.Spano, F.Andre, L.Morat, L.Sabatier, B.Besse, C.Combadiere, P.Deterre, A.Martin, J.Azorin, D.Valeyre, et al. Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcome. Ann Oncol: Off JEur Soci Med Oncol / ESMO 2004; 15:613-7; PMID:NOT_FOUND; http://dx.doi.org/10.1093/annonc/mdh136
9. O.Wald, O.M.Shapira, U.Izhar. CXCR4/CXCL12 axis in non small cell lung cancer (NSCLC) pathologic roles and therapeutic potential. Theranostics 2013; 3:26-33; PMID:23382783; http://dx.doi.org/10.7150/thno.4922
10. S.Singh, R.Singh, U.P.Singh, S.N.Rai, K.R.Novakovic, L.W.Chung, P.J.Didier, W.E.Grizzle, J.W.Lillard, Jr. Clinical and biological significance of CXCR5 expressed by prostate cancer specimens and cell lines. Int J Cancer J Int du Cancer 2009; 125:2288-95; PMID:19610059; http://dx.doi.org/10.1002/ijc.24574
11. S.Singh, U.P.Singh, J.K.Stiles, W.E.Grizzle, J.W.Lillard, Jr. Expression and functional role of CCR9 in prostate cancer cell migration and invasion. Clin Cancer Res: Off J Am Assoc Cancer Res 2004; 10:8743-50; PMID:15623660; http://dx.doi.org/10.1158/1078-0432.CCR-04-0266
12. S.A.Shulby, N.G.Dolloff, M.E.Stearns, O.Meucci, A.Fatatis. CX3CR1-fractalkine expression regulates cellular mechanisms involved in adhesion, migration, and survival of human prostate cancer cells. Cancer Res 2004; 64:4693-8; PMID:15256432; http://dx.doi.org/10.1158/0008-5472.CAN-03-3437
13. D.Vindrieux, P.Escobar, G.Lazennec. Emerging roles of chemokines in prostate cancer. Endocr-Relat Cancer 2009; 16:663-73; PMID:19556286; http://dx.doi.org/10.1677/ERC-09-0109
14. A.Muller, B.Homey, H.Soto, N.Ge, D.Catron, M.E.Buchanan, T.McClanahan, E.Murphy, W.Yuan, S.N.Wagner, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001; 410:50-6; PMID:11242036; http://dx.doi.org/10.1038/35065016
15. Z.Zhang, C.Ni, W.Chen, P.Wu, Z.Wang, J.Yin, J.Huang, F.Qiu. Expression of CXCR4 and breast cancer prognosis: a systematic review and meta-analysis. BMC Cancer 2014; 14:49; PMID:24475985; http://dx.doi.org/10.1186/1471-2407-14-49
16. T.Kakinuma, S.T.Hwang. Chemokines, chemokine receptors, and cancer metastasis. J Leukoc Biol 2006; 79:639-51; PMID:16478915; http://dx.doi.org/10.1189/jlb.1105633
17. R.Singh, C.R.Stockard, W.E.Grizzle, J.W.Lillard, Jr., S.Singh. Expression and histopathological correlation of CCR9 and CCL25 in ovarian cancer. Int J Oncol 2011; 39:373-81; PMID:21637913
18. S.Neogy, S.Das, S.K.Mahapatra, N.Mandal, S.Roy. Amelioratory effect of andrographis paniculata nees on liver, kidney, heart, lung and spleen during nicotine induced oxidative stress. Environ Toxicol Pharmacol 2008; 25:321-8; PMID:21783869; http://dx.doi.org/10.1016/j.etap.2007.10.034
19. P.K.Singha, S.Roy, S.Dey. Protective activity of andrographolide and arabinogalactan proteins from Andrographis paniculata Nees. against ethanol-induced toxicity in mice. J Ethnopharmacol 2007; 111:13–21.
20. M.-D.Shi, H.-H.Lin, Y.-C.Lee, J.-K.Chao, R.-A.Lin, J.-H.Chen. Inhibition of cell-cycle progression in human colorectal carcinoma Lovo cells by andrographolide. Chemico-Biological Interactions 2008; 174:201-10; PMID:18619950; http://dx.doi.org/10.1016/j.cbi.2008.06.006
21. J.Yan, Y.Chen, C.Fau - He, C.He Z.-Z.Fau - Yang, Z.Z.Yang C.Fau - Lu, C.Lu X.-S.Fau - Chen, X.S.Chen. Andrographolide induces cell cycle arrest and apoptosis in human rheumatoid arthritis fibroblast-like synoviocytes.
22. J.M.Gudas, M.Payton, S.Thukral, E.Chen, M.Bass, M.O.Robinson, S.Coats. Cyclin E2, a novel G1 cyclin that binds Cdk2 and is aberrantly expressed in human cancers. Mol Cell Biol 1999; 19:612-22; PMID:9858585; http://dx.doi.org/10.1128/MCB.19.1.612
23. Y.T.Tung, H.L.Chen, H.C.Tsai, S.H.Yang, Y.C.Chang, C.M.Chen. Therapeutic potential of andrographolide isolated from the leaves of andrographis paniculata nees for treating lung adenocarcinomas. Evidence-based Complementary and Alternative medicine: eCAM 2013; 2013:305898; PMID:23997793
24. L.J.Wang, X.Zhou, W.Wang, F.Tang, C.L.Qi, X.Yang, S.Wu, Y.Q.Lin, J.T.Wang, J.G.Geng. Andrographolide inhibits oral squamous cell carcinogenesis through NF-kappaB inactivation. J Dent Res 2011; 90:1246-52; PMID:21841043; http://dx.doi.org/10.1177/0022034511418341
25. C.Tapia-Rojas, A.Schuller, C.B.Lindsay, R.C.Ureta, C.Mejias-Reyes, J.Hancke, F.Melo, N.C.Inestrosa. Andrographolide activates the canonical Wnt signalling pathway by a mechanism that implicates the non-ATP competitive inhibition of GSK-3beta: autoregulation of GSK-3beta in vivo. Biochem J 2015; 466:415-30; PMID:25423492; http://dx.doi.org/10.1042/BJ20140207
26. R.A.Woo, R.Y.Poon. Cyclin-dependent kinases and S phase control in mammalian cells. Cell cycle (Georgetown, Tex) 2003; 2:316-24; PMID:12851482; http://dx.doi.org/10.4161/cc.2.4.468
27. R.D.Mashal, S.Lester, C.Corless, J.P.Richie, R.Chandra, K.J.Propert, A.Dutta. Expression of cell cycle-regulated proteins in prostate cancer. Cancer Res 1996; 56:4159-63; PMID:8797586
28. A.Dutta, R.Chandra, L.M.Leiter, S.Lester. Cyclins as markers of tumor proliferation: immunocytochemical studies in breast cancer. Proc Nat Acad SciU S A 1995; 92:5386-90; PMID:7539916; http://dx.doi.org/10.1073/pnas.92.12.5386
29. A.M.Egloff, J.Weissfeld, S.R.Land, O.J.Finn. Evaluation of anticyclin B1 serum antibody as a diagnostic and prognostic biomarker for lung cancer. AnnNew York Acad Sci 2005; 1062:29-40; PMID:16461786; http://dx.doi.org/10.1196/annals.1358.005
30. A.Hagting, M.Jackman K.Fau - Simpson, K.Simpson J.Fau - Pines, J.Pines. Translocation of cyclin B1 to the nucleus at prophase requires a phosphorylation-dependent nuclear import signal.
31. I.M.Ornelas, T.M.Silva, L.Fragel-Madeira, A.L.M.Ventura Inhibition of PI3K/Akt pathway impairs G2/M transition of cell cycle in late developing progenitors of the avian embryo retina. PloS one 2013; 8:e53517; PMID:23301080; http://dx.doi.org/10.1371/journal.pone.0053517
32. Y.Li, P.Zhang, F.Qiu, L.Chen, C.Miao, J.Li, W.Xiao, E.Ma. Inactivation of PI3K/Akt signaling mediates proliferation inhibition and G2/M phase arrest induced by andrographolide in human glioblastoma cells. Life Sci 2012; 90:962-7; PMID:AMBIGUOUS; http://dx.doi.org/10.1016/j.lfs.2012.04.044
33. D.Gong, J.E.Ferrell. The Roles of Cyclin A2, B1, and B2 in Early and Late Mitotic Events. Mol Biol Cell 2010; 21:3149-61; PMID:20660152; http://dx.doi.org/10.1091/mbc.E10-05-0393
34. T.K.Fung, H.T.Ma, R.Y.Poon. Specialized roles of the two mitotic cyclins in somatic cells: cyclin A as an activator of M phase-promoting factor. Mol Biol Cell 2007; 18:1861-73; PMID:17344473; http://dx.doi.org/10.1091/mbc.E06-12-1092
35. C.Y.Hsieh, M.J.Hsu, G.Hsiao, Y.H.Wang, C.W.Huang, S.W.Chen, T.Jayakumar, P.T.Chiu, Y.H.Chiu, J.R.Sheu. Andrographolide enhances nuclear factor-kappaB subunit p65 Ser536 dephosphorylation through activation of protein phosphatase 2A in vascular smooth muscle cells. J Biol Chem 2011; 286:5942–55.
36. M.Donzelli, G.F.Draetta. Regulating mammalian checkpoints through Cdc25 inactivation. EMBO reports 2003; 4:671-7; PMID:12835754; http://dx.doi.org/10.1038/sj.embor.embor887
37. T.Hunter Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell 1995; 80:225-36; PMID:7834742; http://dx.doi.org/10.1016/0092-8674(95)90405-0
38. S.Atherton-Fessler, F.Liu, B.Gabrielli, M.S.Lee, C.Y.Peng, H.Piwnica-Worms. Cell cycle regulation of the p34cdc2 inhibitory kinases. Mol Biol Cell 1994; 5:989-1001; PMID:7841526; http://dx.doi.org/10.1091/mbc.5.9.989
39. R.J.Duronio Developing S-phase control. Genes Dev 2012; 26:746-50; PMID:22508722; http://dx.doi.org/10.1101/gad.191171.112
40. G.Liu, G.Lozano. p21 stability: linking chaperones to a cell cycle checkpoint. Cancer Cell 2005; 7:113–4.
41. C.Liu, N.Nadiminty, R.Tummala, J.Y.Chun, W.Lou, Y.Zhu, M.Sun, C.P.Evans, Q.Zhou, A.C.Gao. Andrographolide targets androgen receptor pathway in castration-resistant prostate cancer. Genes Cancer 2011; 2:151–9.
42. S.H.Liu, C.H.Lin, F.P.Liang, P.F.Chen, C.D.Kuo, M.M.Alam, B.Maiti, S.K.Hung, C.W.Chi, C.M.Sun, Andrographolide downregulates the v-Src and Bcr-Abl oncoproteins and induces Hsp90 cleavage in the ROS-dependent suppression of cancer malignancy. Biochem Pharmacol 2014; 87:229–42.
43. S.Cialfi, R.Palermo, S.Manca, C.De Blasio, P.Vargas Romero, S.Checquolo, D.Bellavia, D.Uccelletti, M.Saliola, A.D'Alessandro, Loss of Notch1-dependent p21(Waf1/Cip1) expression influences the Notch1 outcome in tumorigenesis. Cell Cycle 2014; 13:2046–55.
44. M.O.Aksoy, Y.Yang, R.Ji, P.J.Reddy, S.Shahabuddin, J.Litvin, T.J.Rogers, S.G.Kelsen. CXCR3 surface expression in human airway epithelial cells: cell cycle dependence and effect on cell proliferation. Am J Physiol Lung Cell Mol Physiol 2006; 290:L909-18; PMID:16339779; http://dx.doi.org/10.1152/ajplung.00430.2005
45. M.R.Rani, G.R.Foster, S.Leung, D.Leaman, G.R.Stark, R.M.Ransohoff. Characterization of beta-R1, a gene that is selectively induced by interferon beta (IFN-beta) compared with IFN-alpha. J Biol Chem 1996; 271:22878-84; PMID:8798467; http://dx.doi.org/10.1074/jbc.271.37.22878
46. T.Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth 1983; 65:55-63; PMID:6606682; http://dx.doi.org/10.1016/0022-1759(83)90303-4